Drug Patents owned by Purple Biotech

1. List of Consensi drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9662315 PURPLE BIOTECH Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
May, 2029

(6 years from now)

US9408837 PURPLE BIOTECH Ameliorating drug-induced elevations in blood pressure by adjunctive use of antihypertensive drugs
Feb, 2030

(7 years from now)

US10925835 PURPLE BIOTECH Celecoxib and amlodipine formulation and method of making the same
Jun, 2038

(15 years from now)

US10945960 PURPLE BIOTECH Celecoxib and amlodipine formulation and method of making the same
Jun, 2038

(15 years from now)

US10350171 PURPLE BIOTECH Celecoxib and amlodipine formulation and method of making the same
Jun, 2038

(15 years from now)

Drugs and Companies using AMLODIPINE BESYLATE; CELECOXIB ingredient

Market Authorisation Date: 31 May, 2018

Treatment: Treatment of adult patients for whom treatment with both amlodipine for hypertension and celecoxib for osteoarthritis are appropriate

Dosage: TABLET;ORAL

How can I launch a generic of CONSENSI before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in